Several studies have evaluated how AOD-9604 affects the body in the context of weight loss
At the forefront of this transformation is a powerful new combination therapy known as the Weight Loss Blend , featuring three synergistic peptides: SLU-PP-332 a PPAR agonist for metabolic enhancement 5-Amino-1MQ a fat loss catalyst targeting methylation and energy balance BPC-157 a regenerative peptide known for gut, vascular, and tissue healing Together, they offer a multidimensional strategy for sustainable fat loss, improved energy, reduced inflammation, and accelerated tissue repair
Doubling your dose does not double your results
Some studies suggest that it may help in reducing body fat, although its effectiveness can vary from person to person
Some practitioners theorize that local administration to abdominal fat may enhance regional lipolytic effects, though this has not been conclusively proven
For women over 40 or those approaching menopause , hormonal changes can affect fat metabolism and peptide response